ClearBridge Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.83M | Sell |
|
|||||
|
2025
Q2 | $4.98M | Sell |
|
|||||
|
2025
Q1 | $6.6M | Buy |
|
|||||
|
2024
Q4 | $5.46M | Sell |
|
|||||
|
2024
Q3 | $5M | Sell |
|
|||||
|
2024
Q2 | $4.41M | Sell |
|
|||||
|
2024
Q1 | $6.73M | Sell |
|
|||||
|
2023
Q4 | $6.46M | Buy |
|
|||||
|
2023
Q3 | $6.53M | Buy |
|
|||||
|
2023
Q2 | $7.16M | Sell |
|
|||||
|
2023
Q1 | $8.09M | Sell |
|
|||||
|
2022
Q4 | $8.6M | Sell |
|
|||||
|
2022
Q3 | $8.63M | Sell |
|
|||||
|
2022
Q2 | $9.36M | Sell |
|
|||||
|
2022
Q1 | $11.9M | Sell |
|
|||||
|
2021
Q4 | $10.3M | Sell |
|
|||||
|
2021
Q3 | $9.93M | Buy |
|
|||||
|
2021
Q2 | $11.1M | Buy |
|
|||||
|
2021
Q1 | $10.3M | Buy |
|
|||||
|
2020
Q4 | $8.15M | Sell |
|
|||||
|
2020
Q3 | $62.1M | Sell |
|
|||||
|
2020
Q2 | $125M | Sell |
|
|||||
|
2020
Q1 | $125M | Sell |
|
|||||
|
2019
Q4 | $162M | Buy |
|
|||||
|
2019
Q3 | $124M | Buy |
|
|||||
|
2019
Q2 | $110M | Buy |
|
|||||
|
2019
Q1 | $96.8M | Sell |
|
|||||
|
2018
Q4 | $157M | Sell |
|
|||||
|
2018
Q3 | $190M | Buy |
|
|||||
|
2018
Q2 | $150M | Sell |
|
|||||
|
2018
Q1 | $173M | Buy |
|
|||||
|
2017
Q4 | $163M | Sell |
|
|||||
|
2017
Q3 | $170M | Sell |
|
|||||
|
2017
Q2 | $149M | Sell |
|
|||||
|
2017
Q1 | $155M | Sell |
|
|||||
|
2016
Q4 | $167M | Sell |
|
|||||
|
2016
Q3 | $273M | Buy |
|
|||||
|
2016
Q2 | $359M | Buy |
|
|||||
|
2016
Q1 | $296M | Buy |
|
|||||
|
2015
Q4 | $310M | Buy |
|
|||||
|
2015
Q3 | $265M | Sell |
|
|||||
|
2015
Q2 | $300M | Sell |
|
|||||
|
2015
Q1 | $300M | Buy |
|
|||||
|
2014
Q4 | $262M | Sell |
|
|||||
|
2014
Q3 | $249M | Buy |
|
|||||
|
2014
Q2 | $201M | Sell |
|
|||||
|
2014
Q1 | $231M | Buy |
|
|||||
|
2013
Q4 | $191M | Buy |
|
|||||
|
2013
Q3 | $166M | Buy |
|
|||||
|
2013
Q2 | $116M | Buy |
|